Literature DB >> 2765230

Craniofacial resection of ossifying fibromas and osteomas of the sinuses.

A Blitzer1, K D Post, J Conley.   

Abstract

Massive fibro-osseous lesions of the frontal and ethmoidal sinuses are rare. If left untreated, these lesions can produce chronic infection, orbital complications, and/or intracranial events. In the past, resection of these lesions has usually been subtotal and a risk of damage to intracranial structures existed, particularly to the dura, due to poor exposure, and a high recurrence rate was also present. We have treated eight such lesions with a combined craniofacial approach for total resection with resolution of symptoms, without recurrence, and without occurrence of cerebrospinal fluid leak, damage to the orbital contents or intracranial structures, or resultant cosmetic deformity.

Entities:  

Mesh:

Year:  1989        PMID: 2765230     DOI: 10.1001/archotol.1989.01860330102027

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Endoscopic resection of sinonasal ossifying fibroma: 31 cases report at an institution.

Authors:  Huan Wang; Xicai Sun; Quan Liu; Jingjing Wang; Dehui Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-21       Impact factor: 2.503

2.  Treatment Challenges with Benign Bone Tumors of the Orbit.

Authors:  Helen Merritt; Vivian T Yin; Margaret L Pfeiffer; Wei-Lien Wang; Matthew C Sniegowski; Bita Esmaeli
Journal:  Ocul Oncol Pathol       Date:  2015-02-10

3.  Endoscopic treatment of nasolacrimal sac obstruction secondary to fibrous dysplasia of paranasal sinuses.

Authors:  Prakash Zodpe; Seung-Won Chung; Hee Joon Kang; Sang Hag Lee; Heung-Man Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-04       Impact factor: 3.236

4.  Spatial and temporal adaptation of predictive saccades based on motion inference.

Authors:  Takeshi D Itoh; Ryuji Takeya; Masaki Tanaka
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.